Although teams experienced comparable hazard variables and First eye circumstances, the HBOT group, Even with currently being older with shorter symptom length, showed noticeably improved remaining eyesight soon after modifying for age, sex, and symptom duration. The research implies introducing HBOT to plain care improves remaining Visible outcome